Continuum
OUR AIMS AND OBJECTIVES
We aim to discover via immuno-oncology
• Early cancer biomarkers
• How viruses can destroy cancer
• Broad spectrum cancer vaccinations
• Broad spectrum drugable cancer cures
• Individual cell based therapies
A UNIQUE AND FOCUSED APPROACH
• Research on extreme phenotypes’ blood and tissue
• Highly respected universities involved
• Highly respected professorial-lead teams (with industry leading knowledge and experience)
• Collaboration and sharing discoveries
• Links to major pharma and other cutting-edge research
• I.P. protected
• Minimal bureaucracy and maximum efficiency
• Use cutting edge technology
OUR AIMS AND OBJECTIVES
We aim to discover via immuno-oncology
• Early cancer biomarkers
• How viruses can destroy cancer
• Broad spectrum cancer vaccinations
• Broad spectrum drugable cancer cures
• Individual cell based therapies
A UNIQUE AND FOCUSED APPROACH
• Research on extreme phenotypes’ blood and tissue
• Highly respected universities involved
• Highly respected professorial-lead teams (with industry leading knowledge and experience)
• Collaboration and sharing discoveries
• Links to major pharma and other cutting-edge research
• I.P. protected
• Minimal bureaucracy and maximum efficiency
• Use cutting edge technology
OUR USP IS THAT WE KNOW WHERE TO LOOK
With an established cohort of cancer survivors (extreme phenotypes, exceptional responders, immunotherapy successes) as donors of blood, tissue and tumour, we are actively researching what it is that enables these rare individuals to survive.
We are not using animals or in vitro experiments but will identify the successful factor(s) that cancer survivors (extreme phenotypes) hold within their bodies
THE FUTURE
• Future collaboration with institutions in the USA and mainland Europe
• Due to rapidity of immuno-oncology research, new machinery is required
• Drug trials / vaccinations
We at Continuum truly believe that our work will help millions of people around the globe.